Studie der Deutschen Larynx-Organerhaltstudiengruppe (DeLOS)

Multizentrische, prospektive und nicht randomisierte Pilotstudie zur funktionserhaltenden Therapie beim fortgeschrittenen primär operablen Larynx- und Hypopharynxkarzinom: Induktionschemotherapie mit Paclitaxel und Cisplatin mit anschließender akzelerierter-hyperfraktionierter Strahlentherapie bei Respondern auf die Chemotherapie.
Studienleitung: Prof. Dr. med. Andreas Dietz; Univ. HNO-Klinik Leipzig andreas.dietz@medizin.uni-leipzig.de

FOSCAN-Studie

A Multicentre, Open-Label, Single-Group Study of Foscan-Photodynamic Therapy (PDT) in the Palliative Treatment of Patients with advanced Squamous Cell Carcinoma of the Head and Neck who have failed Prior Therapies and are Unsuitable for Curative Therapy with Radiotherapy, Surgery or Systemic Chemotherapy

Cisplatin / Epinephrin Gel Studie

A randomized, double-blind, placebo controlled study to evaluate the effect of cisplatin/epinephrine injectable gel (product MPI 5010) when administred intratumorally for achievement of treatment goals in recurrent or refractory squamous cell carcinoma of the head & neck.
Code: MP # 514-94-2
Sponsor: Matrix Pharmaceutical, Inc., Frement Ca, USA

IL-2 Gen Studie

A multi-center study of the safety, tolerability, and clinical efficacy of multiple intratumoral injections of IL-2 gene medicine given in combination  with standard chemotherapy in patients with recurrent or refractory squamous cell carcinoma of the head & neck.
Code: VA01, IL-2-2002
Sponsor: Valentis, Inc., Texas, USA